News

  1. Stevanato Group And Gerresheimer AG Present EZ-Fill Smart, A New And Innovative Ready-To-Use Vial Platform 11/1/2022

    Leveraging the established EZ-fill® market leading technology, process, and product optimization to improve quality, reduce total cost of ownership, and shorten lead times.

  2. Terumo Pharmaceutical Solutions Expands CDMO Services Outside Japan For Global Market 10/31/2022

    Terumo Pharmaceutical Solutions (TPS), a division of Terumo Corporation and a leading manufacturer of injection, primary container, and infusion therapy devices, has today announced it will expand its contract development and manufacturing services for parenteral drugs to global customers.

  3. Cingulate Announces Agreement With Societal CDMO And Provides Clinical Update 10/24/2022

    Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced it has executed a Master Services Agreement (MSA) with Societal CDMO, Inc. (NASD: SCTL), a bi-coastal contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development.

  4. INCOG BioPharma Primes Multi-Use Filling Line For Launch 10/19/2022

    INCOG BioPharma Services, a contract development and manufacturing organization (CDMO), specializing in sterile injectables, has achieved another milestone by completing the installation of its state-of-the-art OPTIMA MultiUse production filling line at its Fishers headquarters.

  5. Stevanato Group Collaborates With IL Group To Improve Safe Processing And Handling Of Hazardous Injectable Drugs 10/12/2022

    The new integrated solution will leverage high-value solutions for drug containment (vials) and container protection (labels) to improve and facilitate the handling and storage of sensitive drugs, as well as ensure higher levels of safety for healthcare professionals and patients.

  6. scPharmaceuticals Announces FDA Approval Of FUROSCIX® (Furosemide Injection) 10/11/2022

    scPharmaceuticals Inc. announced that the U.S. Food and Drug Administration (FDA) has approved FUROSCIX® (furosemide injection), a proprietary formulation of furosemide delivered via an On-Body Infusor for the treatment of congestion due to fluid overload in adults with New York Heart Association Class II/III chronic heart failure.

  7. ten23 Health Completes The Superstructure Of Their New Large-Scale Sterile Production Facility In Visp, Switzerland 9/19/2022

    With the initial phase of construction now complete, ten23 will commence with interior construction andhiring of further team members. The sterile manufacturing plant is well on track to be operational in 2024 for global commercial supplies of injectable drugs

  8. Grand River Aseptic Manufacturing To Fill And Finish Smallpox/Monkeypox Vaccines And Accelerate Domestic Supply 8/19/2022

    Grand River Aseptic Manufacturing (“GRAM”), a prominent parenteral drug product contract development and manufacturing organization (CDMO), has entered into an agreement with Bavarian Nordic, a Denmark-based vaccine company, to fill and finish JYNNEOS smallpox/monkeypox vaccine

  9. Grand River Aseptic Manufacturing Completes Phase II Expansion With Installation Of Two New Sterile Filling Lines 8/17/2022

    Grand River Aseptic Manufacturing (“GRAM”), a prominent parenteral drug product contract development and manufacturing organization (CDMO), has completed Phase II of its facility expansion which includes the installation of GRAM’s two new sterile Bausch+Ströbel filling lines

  10. West Makes Minority Investment In Dublin-Based Latch Medical, A Developer Of Vaccine And Biologics Delivery Platforms 8/15/2022

    West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced it has made a strategic investment in Latch Medical, a Dublin-based leader in next-generation vaccine and biologics delivery technology that is pioneering a new approach to intradermal delivery.